Anesthesia in Oral and Maxillofacial Surgery

Section: Introductionmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

Untitled

2023

“…The incidence of inflammatory complications after the surgical stage of dental implantation, according to different authors, ranges from 0.4 to 5 percent. [1][2][3][4][5] With dental implantation, both early and late inflammatory complications can develop. [6][7][8][9][10] The leading factors in the development of early post-implantation inflammatory complications are considered to be exogenous intrusion of microorganisms, exacerbation of endogenous inflammatory foci, traumatic factor of the surgery, overheating of the bone when drilling the bone bed.…”

Section: Introductionmentioning

confidence: 99%

Prevention of Post-Implantation Inflammatory Complications

Tymofieiev

Ripa

Havlytiuk

et al. 2022

Self Cite

Purpose: Currently, dental prosthetics on endosseous implants is used in most dental clinics of Ukraine. The incidence of inflammatory complications after the surgical stage of dental implantation, according to different authors, ranges from 0.4 to 5 percent. Therefore, many doctors during the surgical stage of dental implantation are looking for medications that simultaneously have both anti-inflammatory and analgesic effects. The purpose of this study is to determine the effectiveness of the treatment of early post-implantation complications when using the drug “Trachisan®” and compare its effectiveness with the traditionally used therapy. Materials and Methods: According to our observation, there were 24 patients aged from 20 to 56 years (1st observation group or main group). We prescribed Trachisan to these patients in the post-implantation period for 4 days. The control group consisted of 30 patients (2nd observation group or the control group), who were treated with traditional methods in the post-implantation period (Analgin tablets [metamizole sodium] and conventional antiseptic rinses). Results: Inflammatory complications in the 1st (main) group were not detected, and in the 2nd (control) group, inflammatory complications were diagnosed in 7 patients (23.3 percent), namely: mucositis – in 4 patients (13.3 percent) and peri-implantitis – in 3 patients (10 percent). Conclusions: Thus, the drug “Trachisan” should be recommended for widespread use in maxillofacial surgery after the surgical stage of dental implantation to prevent post-implantation inflammatory complications.

“…Among the inflammatory complications that develop after performing an extraction operation of impacted and ectopic wisdom teeth are the following: inflammatory infiltration of the surrounding soft tissues and dry socket 1 (also known as alveolar osteitis, 2,3 postextraction alveolar osteitis, 4 and alveolitis in some East European countries [5][6][7] ).…”

Section: Introductionmentioning

confidence: 99%

“…The aim of this research is to determine the effectiveness of the "Tantum Verde®" for the prevention of inflammatory complications in patients after performing an extraction operation of impacted (also known as retained [4][5][6][7] ) and ectopic wisdom teeth.…”

Section: Introductionmentioning

confidence: 99%

Prevention of Inflammatory Complications after Atypical Tooth Removal

Tymofieiev

Sokoliuk

Ripa

et al. 2022

Self Cite

Purpose: To determine the effectiveness of the “Tantum Verde®” drug for the prevention of inflammatory complications in patients after performing an extraction operation of impacted and ectopic wisdom teeth. Materials and Methods: Seventy patients after an extraction operation of impacted and ectopic wisdom teeth were examined. We have divided the surveyed patients into two observation groups: the main group is 34 patients, who have used “Tantum Verde®” drug (Aziende Chimiche Riunite Angelini Francesco A.C.R.A.F. S.p.A., Ancona, Italy) to prevent inflammatory complications in the oral cavity for 4-5 days and a control group – 36 patients with common preventive Furacilin mouthwash (also for 4-5 days). Results and Discussion: Inflammatory infiltration of the mucous membrane of the retromolar region in the area of the postoperative wound, on the next day after the surgery, was in all patients (100%), both in the main and in the control group. In the main group, 20 patients had moderate inflammatory infiltration of the mucous membrane (58.8%), and insignificant – in 14 patients (41.2%). In the control group: moderate infiltration – in 22 patients (61.1%), and insignificant – in 14 patients (38.9%). 2-3 days after surgery, in the main group, moderate inflammatory infiltration of the retromolar region was in 13 patients (38.2%), and insignificant – in 21 patients (61.8%). In the control group: moderate infiltration – in 24 patients (in 66.7%), and insignificant – in 12 patients (in 33.3%). In 5-6 days after the surgery, in the main group an inflammatory infiltration of the mucous membrane of the retromolar region was insignificant in all patients (in 100%). In the control group: moderate infiltration persisted in 8 patients (in 22.2%), and insignificant – in 30 patients (in 77.8%). Conclusions: Based on our researches we can conclude that the hygienic care of the oral cavity with the “Tantum Verde®” drug in patients after the removal of impacted wisdom teeth is more effective, than traditional means. It has been proven that the non-steroidal drug “Tantum Verde” has an expressed anti-inflammatory effect, and also provides a good cleaning of the postoperative wound in the retromolar region. The use of our method of hygienic treatment of the oral cavity in this contingent of patients can significantly reduce the number of postoperative inflammatory complications. The proposed method of the oral cavity care in patients after surgical treatment for the removal of impacted wisdom teeth is the most effective for preventing the development of inflammatory complications and is recommended for use both in maxillofacial hospitals and in surgical departments of dental clinics.